1. Home
  2. MPX vs GLSI Comparison

MPX vs GLSI Comparison

Compare MPX & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marine Products Corporation

MPX

Marine Products Corporation

HOLD

Current Price

$7.44

Market Cap

319.2M

Sector

Industrials

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$25.26

Market Cap

372.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPX
GLSI
Founded
1965
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.2M
372.0M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
MPX
GLSI
Price
$7.44
$25.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$50.00
AVG Volume (30 Days)
33.3K
150.2K
Earning Date
04-23-2026
04-14-2026
Dividend Yield
7.85%
N/A
EPS Growth
N/A
N/A
EPS
0.32
N/A
Revenue
$244,419,000.00
N/A
Revenue This Year
$13.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.13
N/A
Revenue Growth
3.32
N/A
52 Week Low
$6.83
$7.78
52 Week High
$10.08
$34.10

Technical Indicators

Market Signals
Indicator
MPX
GLSI
Relative Strength Index (RSI) 45.80 47.90
Support Level $6.83 $21.43
Resistance Level $9.16 $29.91
Average True Range (ATR) 0.17 2.25
MACD 0.07 -0.19
Stochastic Oscillator 78.38 35.48

Price Performance

Historical Comparison
MPX
GLSI

About MPX Marine Products Corporation

Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

Share on Social Networks: